Physician profile
David Kent
NPI 1477758787
$6,371.60
in general payments reported to CMS, 2019-2025
35 companies · $1,313 in 2025
The $1,313 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $425 · 2021: $448 · 2022: $758 · 2023: $1,814 · 2024: $497 · 2025: $1,313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,929 · Travel and Lodging: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,928.63 |
| Travel and Lodging | $695.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,698.81 | 2019-2025 | Moses 550 D\F\L, Axonics, Rezum Generator |
| Coloplast Corp | $520.94 | 2020-2025 | Altis |
| Astellas Pharma US INC | $501.63 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $430.34 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $385.86 | 2023-2025 | Prolaris |
| Endo Pharmaceuticals INC. | $345.95 | 2019-2023 | Aveed, Xiaflex |
| Sumitomo Pharma America, INC. | $286.82 | 2023-2025 | Gemtesa, Orgovyx |
| C. R. Bard, INC. & Subsidiaries | $263.40 | 2019-2023 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $228.67 | 2022 | |
| Allergan, INC. | $210.68 | 2019-2022 | |
| Agiliti Surgical, INC. | $187.59 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Endo USA, INC. | $175.27 | 2024-2025 | Xiaflex, Aveed |
| Convatec INC. | $169.08 | 2019-2022 | |
| 180 Medical, INC. | $148.89 | 2019-2025 | |
| Axonics, INC. | $126.07 | 2022-2024 | Axonics |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $118.47 | 2021-2022 | |
| Antares Pharma, INC. | $107.83 | 2021-2025 | Xyosted |
| Pfizer INC. | $52.89 | 2019-2022 | |
| Saluda Medical Americas, INC. | $47.83 | 2025 | Evoke |
| Azurity Pharmaceuticals, INC. | $38.09 | 2025 | Azmiro |
| Myovant Sciences INC. | $33.85 | 2021 | |
| Urogen Pharma, INC. | $33.55 | 2025 | |
| Averitas Pharma INC. | $27.54 | 2025 | Qutenza |
| Ambu INC. | $26.97 | 2025 | |
| Mission Pharmacal Company | $26.46 | 2019 | |
| Olympus America INC. | $25.50 | 2023 | Soltive |
| Vertex Pharmaceuticals Incorporated | $24.79 | 2025 | |
| Cook Medical LLC | $19.78 | 2025 | Litho 150 |
| Pacira Pharmaceuticals Incorporated | $19.60 | 2023 | Exparel |
| Halozyme INC | $19.35 | 2023 | |
| Blue Earth Diagnostics | $17.72 | 2022 | |
| Procept Biorobotics Corporation | $14.56 | 2019 | |
| Medtronic, INC. | $14.04 | 2024 | Interstim |
| Ferring Pharmaceuticals INC. | $11.41 | 2019 | |
| Renovia INC | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.